1116 related articles for article (PubMed ID: 22225880)
1. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells.
Le A; Lane AN; Hamaker M; Bose S; Gouw A; Barbi J; Tsukamoto T; Rojas CJ; Slusher BS; Zhang H; Zimmerman LJ; Liebler DC; Slebos RJ; Lorkiewicz PK; Higashi RM; Fan TW; Dang CV
Cell Metab; 2012 Jan; 15(1):110-21. PubMed ID: 22225880
[TBL] [Abstract][Full Text] [Related]
2. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
[TBL] [Abstract][Full Text] [Related]
3. Multiple compartments with different metabolic characteristics are involved in biosynthesis of intracellular and released glutamine and citrate in astrocytes.
Waagepetersen HS; Sonnewald U; Larsson OM; Schousboe A
Glia; 2001 Sep; 35(3):246-52. PubMed ID: 11494415
[TBL] [Abstract][Full Text] [Related]
4. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
Masamha CP; LaFontaine P
J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.
Singleton DC; Dechaume AL; Murray PM; Katt WP; Baguley BC; Leung EY
BMC Cancer; 2020 May; 20(1):470. PubMed ID: 32450839
[TBL] [Abstract][Full Text] [Related]
6. Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells.
Chen L; Cui H; Fang J; Deng H; Kuang P; Guo H; Wang X; Zhao L
Oncotarget; 2016 Aug; 7(34):54691-54701. PubMed ID: 27419628
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Lee JS; Kang JH; Lee SH; Hong D; Son J; Hong KM; Song J; Kim SY
Cell Death Dis; 2016 Dec; 7(12):e2511. PubMed ID: 27929535
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability.
Wise DR; Ward PS; Shay JE; Cross JR; Gruber JJ; Sachdeva UM; Platt JM; DeMatteo RG; Simon MC; Thompson CB
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19611-6. PubMed ID: 22106302
[TBL] [Abstract][Full Text] [Related]
9. Targeting cellular metabolism to reduce head and neck cancer growth.
Yang J; Guo Y; Seo W; Zhang R; Lu C; Wang Y; Luo L; Paul B; Yan W; Saxena D; Li X
Sci Rep; 2019 Mar; 9(1):4995. PubMed ID: 30899051
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
11. Targeting GLS1 to cancer therapy through glutamine metabolism.
Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
Reckzeh ES; Karageorgis G; Schwalfenberg M; Ceballos J; Nowacki J; Stroet MCM; Binici A; Knauer L; Brand S; Choidas A; Strohmann C; Ziegler S; Waldmann H
Cell Chem Biol; 2019 Sep; 26(9):1214-1228.e25. PubMed ID: 31303578
[TBL] [Abstract][Full Text] [Related]
13. Uncovering metabolic reservoir cycles in MYC-transformed lymphoma B cells using stable isotope resolved metabolomics.
Hoang G; Zhang C; Attarwala N; Jung JG; Cooper AJL; Le A
Anal Biochem; 2021 Nov; 632():114206. PubMed ID: 33894159
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Melanoma Cell Glutamine Metabolism by Stable Isotope Tracing and Gas Chromatography-Mass Spectrometry.
Scott DA
Methods Mol Biol; 2021; 2265():91-110. PubMed ID: 33704708
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.
Huang Q; Stalnecker C; Zhang C; McDermott LA; Iyer P; O'Neill J; Reimer S; Cerione RA; Katt WP
J Biol Chem; 2018 Mar; 293(10):3535-3545. PubMed ID: 29317493
[TBL] [Abstract][Full Text] [Related]
16. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport.
Yang C; Ko B; Hensley CT; Jiang L; Wasti AT; Kim J; Sudderth J; Calvaruso MA; Lumata L; Mitsche M; Rutter J; Merritt ME; DeBerardinis RJ
Mol Cell; 2014 Nov; 56(3):414-424. PubMed ID: 25458842
[TBL] [Abstract][Full Text] [Related]
17. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.
Pérez-Escuredo J; Dadhich RK; Dhup S; Cacace A; Van Hée VF; De Saedeleer CJ; Sboarina M; Rodriguez F; Fontenille MJ; Brisson L; Porporato PE; Sonveaux P
Cell Cycle; 2016; 15(1):72-83. PubMed ID: 26636483
[TBL] [Abstract][Full Text] [Related]
18. Influence of Serum and Hypoxia on Incorporation of [(14)C]-D-Glucose or [(14)C]-L-Glutamine into Lipids and Lactate in Murine Glioblastoma Cells.
Ta NL; Seyfried TN
Lipids; 2015 Dec; 50(12):1167-84. PubMed ID: 26537505
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 3-(13)C-malate in primary cultures of mouse astrocytes.
Alves PM; Nunes R; Zhang C; Maycock CD; Sonnewald U; Carrondo MJ; Santos H
Dev Neurosci; 2000; 22(5-6):456-62. PubMed ID: 11111162
[TBL] [Abstract][Full Text] [Related]
20. Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway.
Restall IJ; Cseh O; Richards LM; Pugh TJ; Luchman HA; Weiss S
Cancer Res; 2020 Dec; 80(24):5478-5490. PubMed ID: 33106333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
